Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | PPARG | P37231 | 1/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.58 |
| ▸ | FPR2 | P25090 | 4/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.43 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | CFTR | P13569 | 1/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23064866 | 0.99 | USP2 (0.57) | USP2MEN1BLMKMT2APOLB | |
| Perchlorate SCHEMBL9638625 | 0.97 | USP2 (0.57) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL19000685 | 0.94 | USP2 (0.54) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL10124264 | 0.93 | USP2 (0.56) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL9007850 | 0.92 | USP2 (0.59) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL18350817 | 0.92 | USP2 (0.55) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL22292200 | 0.92 | USP2 (0.55) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL13033323 | 0.91 | USP2 (0.58) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL14393084 | 0.91 | USP2 (0.58) | USP2MEN1BLMKMT2APOLB | |
| SCHEMBL15932542 | 0.91 | USP2 (0.54) | USP2MEN1BLMKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802211-B2 | Polymeric dyes and uses thereof | BECTON, DICKINSON AND COMPANY (US) | 2023-10-31 | — | — | US | disclosed |
| US-11802211-B2 | Polymeric dyes and uses thereof | BECTON, DICKINSON AND COMPANY (US) | 2023-10-31 | — | — | US | disclosed |
| US-20230167303-A1 | COLOR MATCHED AND BRIGHT FLUORESCENT MATERIALS COMPOSED OF SMALL-MOLECULE IONIC LATTICES | UNIVERSITY OF COPENHAGEN (DK) | 2023-06-01 | — | — | US | disclosed |
| US-20230167303-A1 | COLOR MATCHED AND BRIGHT FLUORESCENT MATERIALS COMPOSED OF SMALL-MOLECULE IONIC LATTICES | UNIVERSITY OF COPENHAGEN (DK) | 2023-06-01 | — | — | US | disclosed |
| US-20200407628-A1 | COLOR MATCHED AND BRIGHT FLUORESCENT MATERIALS COMPOSED OF SMALL-MOLECULE IONIC LATTICES | UNIVERSITY OF COPENHAGEN (DK) | 2020-12-31 | — | — | US | disclosed |
| US-20190002717-A1 | INK, TEXTILE PRINTING METHOD, PRINTED TEXTILE AND INK AGENT FOR TEXTILE | JSR CORPORATION (JP) | 2019-01-03 | — | — | US | disclosed |
| US-20150322265-A1 | XANTHENE-BASED PURPLE DYE COMPOUND, COLORING RESIN COMPOSITION FOR COLOR FILTER CONTAINING SAME AND COLOR FILTER USING SAME | KYUNG-IN SYNTHETIC CO., LTD. (KR) | 2015-11-12 | — | — | US | disclosed |
| US-20150322265-A1 | XANTHENE-BASED PURPLE DYE COMPOUND, COLORING RESIN COMPOSITION FOR COLOR FILTER CONTAINING SAME AND COLOR FILTER USING SAME | KYUNG-IN SYNTHETIC CO., LTD. (KR) | 2015-11-12 | — | — | US | disclosed |
| US-8258190-B2 | Encapsulated contrast agents | INTEZYNE TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-8247145-B2 | Magenta toner for developing electrostatic image | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-7776504-B2 | Dye-containing resist composition and color filter using same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-17 | — | — | US | disclosed |
| US-20100160645-A1 | POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | INTEZYNE TECHNOLOGIES, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| US-7618944-B2 | Encapsulating in micelle which is a block copolymer containing hydrophilic and hydrophobic blocks | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-7612153-B2 | conjugate polymer drugs; endcapped polyethers; nontoxic, biocompatible, non-immunogenic, soluble in water and other solvents | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-20090092554-A1 | ENCAPSULATED CONTRAST AGENTS | INTEZYNE TECHNOLOGIES, INC. (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090068581-A1 | Magenta Toner for Developing Electrostatic Image | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080274965-A1 | ENCAPSULATED AMYLOID-BETA PEPTIDES | INTEZYNE TECHNOLOGIES, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | INTEZYNE TECHNOLOGIES (US) | 2008-08-07 | — | — | US | disclosed |
| EP-0212450-B1 | SOLID SCINTILLATOR COUNTING COMPOSITIONS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160645-A1 | POLY(ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDGROUPS | GNE, EPRS1, ALG1 | USP2 746/4885MEN1 2092/4885BLM 1345/4885 |
| US-20080274965-A1 | ENCAPSULATED AMYLOID-BETA PEPTIDES | IAPP, APP, TTR | USP2 1451/4885MEN1 227/4885BLM 2493/4885 |
| US-20080188638-A1 | Heterobifunctional poly(ethyleneglycol) containing acid-labile amino protecting groups and uses thereof | LNPEP, GNE, DNPEP | USP2 253/4885MEN1 2987/4885BLM 2721/4885 |
| US-20090092554-A1 | ENCAPSULATED CONTRAST AGENTS | LIPA, LPXN, CD47 | USP2 1069/4885MEN1 161/4885BLM 469/4885 |
| US-20080274173-A1 | Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery | CLTB, SLC1A5, CLTA | USP2 213/4885MEN1 2136/4885BLM 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.